Wan‐Ru Chao

1.2k total citations
56 papers, 846 citations indexed

About

Wan‐Ru Chao is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Wan‐Ru Chao has authored 56 papers receiving a total of 846 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 12 papers in Oncology and 12 papers in Genetics. Recurrent topics in Wan‐Ru Chao's work include Retinoids in leukemia and cellular processes (17 papers), Estrogen and related hormone effects (12 papers) and HER2/EGFR in Cancer Research (7 papers). Wan‐Ru Chao is often cited by papers focused on Retinoids in leukemia and cellular processes (17 papers), Estrogen and related hormone effects (12 papers) and HER2/EGFR in Cancer Research (7 papers). Wan‐Ru Chao collaborates with scholars based in Taiwan, United States and Japan. Wan‐Ru Chao's co-authors include Marcia I. Dawson, Peter D. Hobbs, Howard L. Johnson, Ronald G. Almquist, Chih‐Ping Han, Ling Jong, Rebecca L. Chan, Ming‐Yung Lee, Magnus Pfahl and Braham Shroot and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Wan‐Ru Chao

51 papers receiving 802 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wan‐Ru Chao Taiwan 18 582 224 133 120 114 56 846
María A. Ortiz United States 18 748 1.3× 203 0.9× 284 2.1× 137 1.1× 75 0.7× 34 1.2k
Filippa Pettersson Canada 18 654 1.1× 104 0.5× 220 1.7× 49 0.4× 40 0.4× 26 884
Jean‐Charles Faye France 19 472 0.8× 258 1.2× 160 1.2× 54 0.5× 12 0.1× 41 855
Rosemary E. Hall Australia 17 701 1.2× 843 3.8× 531 4.0× 56 0.5× 58 0.5× 18 1.5k
Sushma Yadav United States 24 1.0k 1.7× 70 0.3× 496 3.7× 94 0.8× 57 0.5× 47 1.4k
M. Tabrizizad United States 5 507 0.9× 97 0.4× 224 1.7× 191 1.6× 23 0.2× 8 824
Jeffrey D. Bray United States 12 441 0.8× 224 1.0× 139 1.0× 47 0.4× 9 0.1× 20 885
Xiaohua Leng China 13 1.2k 2.0× 552 2.5× 183 1.4× 25 0.2× 27 0.2× 15 1.5k
Jichuang Wang China 24 692 1.2× 65 0.3× 412 3.1× 55 0.5× 23 0.2× 42 1.2k
Ling Jong United States 14 971 1.7× 512 2.3× 137 1.0× 177 1.5× 244 2.1× 22 1.2k

Countries citing papers authored by Wan‐Ru Chao

Since Specialization
Citations

This map shows the geographic impact of Wan‐Ru Chao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wan‐Ru Chao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wan‐Ru Chao more than expected).

Fields of papers citing papers by Wan‐Ru Chao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wan‐Ru Chao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wan‐Ru Chao. The network helps show where Wan‐Ru Chao may publish in the future.

Co-authorship network of co-authors of Wan‐Ru Chao

This figure shows the co-authorship network connecting the top 25 collaborators of Wan‐Ru Chao. A scholar is included among the top collaborators of Wan‐Ru Chao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wan‐Ru Chao. Wan‐Ru Chao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chao, Wan‐Ru, et al.. (2024). HER2 mutations in advanced cervical neuroendocrine carcinoma: implications for trastuzumab deruxtecan therapy. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(10). 7615–7622. 3 indexed citations
2.
Wang, Yuting, et al.. (2022). Primary malignant peritoneal mesothelioma mimicking tuberculous peritonitis: A case report. World Journal of Clinical Cases. 10(10). 3156–3163.
3.
Yeh, Chung‐Min, et al.. (2021). High Expression of MTA1 Predicts Unfavorable Survival in Patients With Oral Squamous Cell Carcinoma. In Vivo. 35(4). 2363–2368. 4 indexed citations
4.
Wang, Chengyou, et al.. (2021). Lung Adenocarcinoma With Primary LIMD1-BRAF Fusion Treated With MEK Inhibitor: A Case Report. Clinical Lung Cancer. 22(6). e878–e880. 10 indexed citations
5.
Chao, Wan‐Ru, et al.. (2020). The Her2 gene aberrations in mucinous ovarian carcinoma: Analysis of twenty-one cases. Taiwanese Journal of Obstetrics and Gynecology. 59(2). 346–347. 7 indexed citations
6.
Chao, Wan‐Ru, et al.. (2016). Mutation-free expression of c-Kit proto-oncogene in primary adenocarcinoma of uterine cervix. Taiwanese Journal of Obstetrics and Gynecology. 55(5). 741–742. 1 indexed citations
10.
Laderoute, Keith R., Joy M. Calaoagan, Wan‐Ru Chao, et al.. (2014). 5′-AMP-activated Protein Kinase (AMPK) Supports the Growth of Aggressive Experimental Human Breast Cancer Tumors. Journal of Biological Chemistry. 289(33). 22850–22864. 57 indexed citations
11.
Chao, Wan‐Ru, et al.. (2014). Assessing the HER2 Status in Mucinous Epithelial Ovarian Cancer on the Basis of the 2013 ASCO/CAP Guideline Update. The American Journal of Surgical Pathology. 38(9). 1227–1234. 17 indexed citations
12.
Chao, Wan‐Ru, Ming‐Yung Lee, Chi‐Kuan Chen, et al.. (2013). HER2 amplification and overexpression are significantly correlated in mucinous epithelial ovarian cancer. Human Pathology. 45(4). 810–816. 20 indexed citations
13.
Lin, Wea‐Lung, et al.. (2011). Bilateral cervical ectopic thymic nodules with accessory thyroid tissue and an ectopic parathyroid in the neck region. SHILAP Revista de lepidopterología. 6(1). 61–64. 1 indexed citations
14.
Yao, Chung‐Chin, et al.. (2009). Mucinous Neuroendocrine Carcinoma of the Breast: Report of a Case. Formosan Journal of Surgery. 42(4). 224–229. 1 indexed citations
15.
Lin, Wea‐Lung, et al.. (2008). High-grade Salivary Duct Carcinoma of the Parotid gland-case Report. Journal of Dental Sciences. 3(4). 222–227.
16.
Dawson, Marcia I., Ling Jong, Peter D. Hobbs, et al.. (2000). 4-[3-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)phenyl]benzoic acid and heterocyclic-bridged analogues are novel retinoic acid receptor subtype and retinoid X receptor α agonists. Bioorganic & Medicinal Chemistry Letters. 10(12). 1311–1313. 12 indexed citations
17.
Dawson, Marcia I., Peter D. Hobbs, Ling Jong, et al.. (2000). sp2-bridged diaryl retinoids: Effects of bridge-region substitution on retinoid x receptor (RXR) selectivity. Bioorganic & Medicinal Chemistry Letters. 10(12). 1307–1310. 8 indexed citations
18.
White, E. Lucile, Wan‐Ru Chao, Larry J. Ross, et al.. (1999). Michellamine Alkaloids Inhibit Protein Kinase C. Archives of Biochemistry and Biophysics. 365(1). 25–30. 17 indexed citations
19.
20.
Dawson, Marcia I., Ling Jong, Peter D. Hobbs, et al.. (1995). Conformational Effects on Retinoid Receptor Selectivity. 2. Effects of Retinoid Bridging Group on Retinoid X Receptor Activity and Selectivity. Journal of Medicinal Chemistry. 38(17). 3368–3383. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026